Collaborative Multidisciplinary Workshop Report: Detection, Culture, Serology, and Antimicrobial Susceptibility Testing ofChlamydia pneumoniae

Lucy S. Tompkins, Julius Schachter, Jens Boman, Scott Dowell, Charlotte A. Gaydos, Matthew E. Levison, Matthias Maass, Guillermo Madico, Jeanne Orfila, Kazunobu Ouchi, Rosanna W. Peeling, David Taylor-Robinson, Walter E. Stamm, San-Pin Wang, Francesco Blasi, and David Relman Departments of Medicine and Microbiology and Immunology, Stanford University Medical Center, Stanford, Laboratory Medicine, Chlamydia Laboratory, University of California, San Francisco, and VA Palo Alto Health Care System, Palo Alto, California; Division of Infectious Diseases and School of Public Health, Johns Hopkins University, Baltimore, Maryland; Department of Medicine and Department of Pathobiology, School of Public Health and Community Medicine, University of Washington, Seattle; Respiratory Disease Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia; Division of Infectious Diseases, Allegheny University Hospital, Medical College of Pennsylvania, Philadelphia; University Hospital of Umeå, Department of Clinical Virology, Umeå, Sweden; Medical University of Lubeck, Institute of Medical Microbiology and Hygiene, Lubeck, Germany; Centre Hospitalier Regional d’Amiens, Laboratoire de Bacteriologie-Immunologie Generale, Amiens, France; Saiseikai Shimonoseki General Hospital, Yamaguchi, Japan; Laboratory Centre for Disease Control, Health Canada, Winnipeg, Canada; Chalfont St. Giles, Bucks, United Kingdom; 16 Institute of Respiratory Diseases, IRCCS Ospedale Maggiore, University of Milan, Italy